Single Blog Title

This is a single blog caption

Saroja Pharma IPO Allotment Status, Date & Time, Refund & Listing

Saroja Pharma IPO Allotment Status

Saroja Pharma IPO Allotment started on 31 August 2023 and those who have submitted their request before 5 September 2023 can check the allotment status on 8 September 2023. To find out more details about the initial public offering (IPO) allotment status stay tuned.

Saroja Pharma IPO Allotment Status

The launch date for Saroja Pharma’s initial public offering (IPO) was August 31 to September 5. A 9.11 crore NSE SME IPO is being conducted by Saroja Pharma. The price range for the Saroja Pharma IPO is defined as 84. With the goal of providing the greatest service delivery in chemistry trade with the top premium pharmaceutical firms in India and overseas for affordable human and animal medicine, Saroja Pharma Industries was founded.

The business deals in pharmaceutical active pharmaceutical ingredients (API), pharmaceutical intermediates, chemicals, and solvents used in human and veterinary medicine. They engage in the trade of Active Pharmaceutical Ingredients, Specialty Chemicals, and Pharmaceutical Intermediates. Additionally, they import, export, and supply specialty chemicals to the real end consumers.

Open Date31 August 2023
Closing Date5 September 2023
Basis of Allotment8 September 2023
Refund Initiation11 September 2023
Listing Date13 September 2023

They consistently deliver customized specialized chemicals in India and internationally in accordance with the wants and demands of the clients. In industries including pharmaceutical, agriculture, and chemicals for humans and animals, Saroja Pharma Specialty Chemicals and its intermediates are widely used.

Saroja Pharma IPO Allotment Refund & Listing

The Saroja Pharma IPO refund will be initiated on 11 September 2023 as per the declared dates and schedule. Candidates can check the listing on 13 September 2023 after the release of the listing candidates can check it using their application number and PAN details. As per updates allotment will be on 8 September 2023 at 10:00 PM and 11 September 2023 at 11:00 AM.

Saroj Pharma IPO Important Dates

Saroj Pharma IPO will start on 31 August 2023 and candidates will have time till 5 September 2023 and the window will close on 5 September 2023. Therefore, you may only do so on the website of KFIN Technologies Limited (formerly Karvy Computershare), the IPO registrar.

The amount of the IPO’s allocation will depend on how much of the retail, HNI/NII, and QIB portions were oversubscribed, and only legitimate applications will be accepted. We shall examine that later, though. Let’s first examine how to see the IPO Saroja Pharma Industries Ltd’s allocation status. These are the procedures.

Saroja Pharma IPO Allotment Status Link

On September 8, 2023, the IPO allotment status will be confirmed. Therefore, the allocation status can be verified online on the website of the IPO registrant either late on September 8, 2023, or by the middle of 9 September 2023. The allocation status of the IPO can typically be found on the BSE website or the website of the IPO’s registrar for all mainboard offerings.

Saroja Pharma Industries Ltd.’s IPO, however, will only be listed on the NSE and not the BSE because it is an NSE-SME Emerge IPO. BSE will not provide the allotment status for this IPO, while NSE typically does not provide online allotment information on its website.

Saroja Pharmaceutical Industries IPO Shares

Saroja Pharma is known for its pharmaceutical products and shares are in high demand. Liquid bromine, which is used as an agricultural intermediate, ethyl acetate, which serves as an API solvent, and numerous medications with applications in both human and veterinary medicine some of which also function as API solvents are just a few of the items offered by Saroja Pharma Industries. APIs, also known as bulk actives or bulk medicines, are essential elements used to create completed dosage forms such as tablets, capsules, liquids, and other dosage formats. They are frequently coupled with additional APIs or inactive compounds.